Cargando…
Repurposable drugs for SARS-CoV-2 and influenza sepsis with scRNA-seq data targeting post-transcription modifications
Coronavirus disease 2019 (COVID-19) has impacted almost every part of human life worldwide, posing a massive threat to human health. The lack of time for new drug discovery and the urgent need for rapid disease control to reduce mortality have led to a search for quick and effective alternatives to...
Autores principales: | Wang, Zhihan, Guo, Kai, Gao, Pan, Pu, Qinqin, Li, Changlong, Hur, Junguk, Wu, Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8694063/ https://www.ncbi.nlm.nih.gov/pubmed/34993416 http://dx.doi.org/10.1093/pcmedi/pbab022 |
Ejemplares similares
-
Identification of Repurposable Drugs and Adverse Drug Reactions for Various Courses of COVID-19 Based on Single-Cell RNA Sequencing Data
por: Wang, Zhihan, et al.
Publicado: (2020) -
In Silico Drug Repurposing in Multiple Sclerosis Using scRNA-Seq Data
por: Shevtsov, Andrey, et al.
Publicado: (2023) -
ScRNA-seq and ST-seq in liver research
por: He, Jia, et al.
Publicado: (2023) -
scRNASequest: an ecosystem of scRNA-seq analysis, visualization, and publishing
por: Li, Kejie, et al.
Publicado: (2023) -
Computational approaches for interpreting scRNA‐seq data
por: Rostom, Raghd, et al.
Publicado: (2017)